2018
DOI: 10.1007/s11906-018-0887-6
|View full text |Cite
|
Sign up to set email alerts
|

Mineralocorticoids and Cardiovascular Disease in Females with Insulin Resistance and Obesity

Abstract: Since the initial isolation of aldosterone in 1953 and the cloning of the mineralocorticoid receptor (MR) decades later, our understanding has expanded tremendously regarding their involvement in the pathogenesis of CVD. Recent results from both pre-clinical and clinical studies support a close correlation between increase adiposity and enhanced aldosterone production (MR activation). Importantly, insulin resistance and obese females are more prone to the deleterious cardiovascular effects of MR activation, an… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
3
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 74 publications
1
3
0
Order By: Relevance
“…Our study further extends our knowledge on the role of myeloid MR activation in mediating vascular stiffening in female mice, which have been shown to be more vulnerable to vascular dysfunction in the setting of elevated aldosterone levels when compared with males (Manrique et al, 2016;Davel et al, 2018). In this study, we did not compare females to males; however, our data support the notion that MR activation contributes to profound vascular dysfunction in females in conditions of enhanced RAAS activity such as obesity and insulin resistance (Mehta et al, 2016;Davel et al, 2018;Nayyar et al, 2018;Shukri et al, 2018).…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…Our study further extends our knowledge on the role of myeloid MR activation in mediating vascular stiffening in female mice, which have been shown to be more vulnerable to vascular dysfunction in the setting of elevated aldosterone levels when compared with males (Manrique et al, 2016;Davel et al, 2018). In this study, we did not compare females to males; however, our data support the notion that MR activation contributes to profound vascular dysfunction in females in conditions of enhanced RAAS activity such as obesity and insulin resistance (Mehta et al, 2016;Davel et al, 2018;Nayyar et al, 2018;Shukri et al, 2018).…”
Section: Discussionsupporting
confidence: 70%
“…In the vasculature, mineralocorticoids elicit dimorphic responses that impact females to a greater extent compared to males ( Mehta et al, 2016 ). Indeed, obese and insulin-resistant women display more frequent and aggressive frequency of CVD compared to men ( Nayyar et al, 2018 ). Although available clinical and preclinical studies have established that MR activation is critical to the development of vascular dysfunction impacting females more severely than males, there is still a lack of knowledge about the relationship between MR activation in myeloid cells and the development of vascular/endothelial dysfunction in females.…”
Section: Introductionmentioning
confidence: 99%
“…The occurrence of IR will not only increase the incidence of diseases such as type 2 diabetes, hypertension, coronary artery disease, stroke, etc. but also increase all-cause mortality of patients with cancer, causing trillions of medical burdens worldwide ( 8 , 30 , 31 , 32 , 33 , 34 , 35 ). The incidence of IR, which remains on the rise, is largely attributable to the failure to recognize its occurrence early.…”
Section: Discussionmentioning
confidence: 99%
“…Obesity, as a chronic disease, has become one of the most serious public health threats of the 21st century [2]. Many studies have noted that obesity and being overweight are generally accompanied by one or more risk factors of cardiovascular disease [3][4][5]. Obesity not only has an association with cardiovascular diseases but also a major cause of liver dysfunction and other related diseases.…”
Section: Introductionmentioning
confidence: 99%